Bcl-x Protects Primary B Cells Against Fas- Mediated Apoptosis

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4834-4839

  Schneider, Thomas J ^a   Grillot, Didier ^b   Foote, Linda C ^a   Núñez, Gabriel E ^b   Rothstein, Thomas L ^a,c  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2L1 PROTEIN, MOUSE; CD40 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 4; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL X;

ANIMAL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MOUSE; PHYSIOLOGY; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; BCL-X PROTEIN; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; UP-REGULATION;

EID: 0031573211     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
2. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
3. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
4. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
5. Owen-Schaub, L. B., S. Yonehara, W. L. Crump III, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
6. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
7. Daniel, P. T., and P. H. Krammer. 1994. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 152:5624.
8. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411.
9. Stanger, B. Z., P. Leder, T.-H. Lee, E. Kim, and B. Seed. 1995. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513.
10. Boldin, M. P., E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Fas/ APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795.
11. Chinnaiyan, A. M., K. O'Rourke, M. Tewari, and V. M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505.
12. Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803.
13. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1995. FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817.
14. Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and M. E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/ CD95)-associatcd proteins (CAP) form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:5579.
15. Enari, M., R. V. Talanian, W. W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723.
16. Rothstein, T. L., J. K. M. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S.-T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.
17. Foote, L. C., T. J. Schneider, G. M. Fischer, J. K. M. Wang, B. Rasmussen, K. A. Campbell, D. H. Lynch, S.-T. Ju, A. Marshak-Rothstein, and T. L. Rothstein. 1996. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J. Immunol. 157:1878.
18. Rothstein, T. L. 1996. Signals and susceptibility to programmed cell death in B cells. Curr. Opin. Immunol. 8:362.
19. Yang, E., and S. J. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88:386.
20. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621.
21. Weller, M., U. Malipiero, A. Aguzzi, J. C. Reed, and A. Fontana. 1995. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J. Clin. Invest. 95:2633.
22. Jaattela, M., M. Benedict, M. Tewari, J. A. Shayman, and V. M. Dixit. 1995. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10:2297.
23. Schroter, M., B. Lowin, C. Borner, and J. Tschopp. 1995. Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2. Eur. J. Immunol. 25:3509.
24. Lee, R. K., J. Spielman, and E. R. Podack. 1996. bcl-2 protects against fas-based but not perforin-based T cell-mediated cytolysis. Int. Immunol. 8:991.
25. Lacronique, V., A. Mignon, M. Fabre, B. Viollet, N. Rouquet, T. Molina, A. Porteu, A. Henrion, D. Bouscary, P. Varlet, V. Joulin, and A. Kahn. 1996. Bcl-x protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2:80.
26. Chiu, V. K., C. M. Walsh, C. C. Liu, J. C. Reed, and W. R. Clark. 1995. Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. J. Immunol. 154:2023.
27. Memon, S. A., M. B. Moreno, D. Petrak, and C. M. Zacarchuk. 1995. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:4644.
28. Strasser, A., A. W. Harris, D. C. Huang, P. H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:6136.
29. Chinnaiyan, A. M., K. Orth, K. O'Rourke, H. Duan, G. G. Poiner, and V. M. Dixit. 1996. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271:4573.
30. Grillot, D. A. M., R. Merino, J. C. Pena, W. C. Fanslow, F. D. Finkelman, C. B. Thompson, and G. Núñez. 1996. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med. 183:381.
31. Xie, W., and L. I. Rothblum. 1991. Rapid, small scale RNA isolation from tissue culture cells. Biotechniques 11:324.
32. Huo, L., and T. L. Rothstein. 1995. Receptor-specific induction of individual AP-1 components in B lymphocytes. J. Immunol. 154:3300.
33. Karras, J. G., Z. Wang, S. J. Coniglio, D. A. Frank, and T. L. Rothstein. 1996. Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-γ activation site. J. Immunol. 157:39.
34. Foote, L. C., R. G. Howard, A. Marshak-Rothstein, and T. L. Rothstein. 1996. IL-4 induces Fas resistance in B cells. J. Immunol. 157:2749.
35. Lane, P. T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209.
36. Francis, D. A., J. G. Karras, X.-Y. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7:151.
37. Fang, W., J. J. Rivard, D. L. Mueller, and T. W. Behrens. 1994. Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J. Immunol. 153:4388.
38. Lagresle, C., P. Mondiere, C. Bella, P. H. Krammer, and T. Defrance. 1996. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J. Exp. Med. 183: 1377.
39. Anderson, J. S., M. Teutsch, Z. Dong, and H. H. Wortis. 1996. An essential role for tyrosine kinase in the regulation of Bruton's B-cell apoptosis. Proc. Natl. Acad. Sci. USA 93:10966.
40. Zhang, X., L. Li, J. Choe, S. Krajewski, J. C. Reed, C. Thompson, and Y. S. Choi. 1996. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Cell. Immunol. 173:149.
41. Choi, M. S., L. H. Boise, A. R. Gottschalk, J. Quintans, C. B. Thompson, and G. G. Klaus. 1995. The role of Bel-XL in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 25:1352.
42. Wang, Z., J. G. Karras, R. G. Howard, and T. L. Rothstein. 1995. Induction of bcl-x by CD40 engagement rescues slg-induced apoptosis in murine B cells. J. Immunol. 155:3722.
43. Ishida, T., N. Kobayashi, T. Tojo, S. Ishida, T. Yamamoto, and J. Inoue. 1995. CD40 signaling-mediated induction of Bel-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth. J. Immunol. 155:5527.
44. Merino, R., D. A. Grillot, P. L. Simonian, S. Muthukkumar, W. C. Fanslow, S. Bondada, and G. Nunez. 1995. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells: dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J. Immunol. 155:3830.